Paper Trade
Login
Home
>
Pharmaceuticals and health care Stocks
>
ZYDUSLIFE
Overview
Tech Summary
Promoter Holding
Posts
ZYDUSLIFE
4
0
1
2
3
4
5
6
7
8
9
8
0
1
2
3
4
5
6
7
8
9
0
0
1
2
3
4
5
6
7
8
9
.
7
0
1
2
3
4
5
6
7
8
9
0
0
1
2
3
4
5
6
7
8
9
-1.60 (-0.33%)
The current prices are delayed.
Login/Sign Up
to see live prices.
Previous Close: 482.3
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
478.8
Today's high
487
52 week low
452.2
52 week high
488.3
Volume
938602
About
Tech Summary
DMA(12)
₹404.22
DMA(50)
₹410.4
DMA(100)
₹389.71
DMA(200)
₹444.11
Fund Summary
Market Cap
₹49209.26 Cr.
Enterprise Value
₹52913.46 Cr.
No. of Shares
102.37
P/E
10.97
RoE
18.3
Debt/Equity
0.35
Valuations
PE Chart
35
40
45
50
55
PB Chart
2.0
2.2
2.4
2.6
2.8
Promoter Holdings
Public : 9.69%
FII : 2.53%
DII : 12.91%
Promoter : 74.88%
Others : 0%
Peer Comparison
Peer companies
SUNPHARMA
PEL
BIOCON
ABBOTINDIA
ZYDUSLIFE
ALKEM
AUROPHARMA
Market Capital (Cr.)
197846.28
39401.02
39253.62
38283.91
36172.44
35943.99
30847.64
P/E
-1978.88
68.84
455.93
48.04
42.17
23.31
21.21
P/B
8.05
1.7
4.85
13.61
2.73
4.11
1.8
Price(₹)
824.9
1627.95
326.65
18039.6
346.4
3034.45
517.5
Charts
❮
❯
Debt/Equity
0.40
0.50
0.60
0.70
Mar, 2018
Mar, 2019
Mar, 2020
Mar, 2021
ROE vs ROCE
10
12
14
16
18
20
22
24
Mar, 2018
Mar, 2019
Mar, 2020
Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
2
4
6
8
10
12
14
16
Mar, 2018
Mar, 2019
Mar, 2020
Mar, 2021
Revenue
Profit
Margins(%)
10
15
20
25
Mar, 2018
Mar, 2019
Mar, 2020
Mar, 2021
Net Margin
Gross Margin
About
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Login / Sign up
Price Target Potential
Brokerage
Sharekhan
Target
480
Potential
29.22%
Stock Sentiments
98% Bullish
2% Bearish
52 live trades of
Rs. 2,962,734.05
V
vrajmehta
Reputation: 0 •
Mar 24 8:31 PM
ZYDUSLIFE
10 Qty (S) Validity Over
-₹14.5
S
shajikumarl
Reputation: 0 •
Mar 24 8:29 PM
ZYDUSLIFE
25 Qty (S) Exited
₹23.75
Posts by FrontPage Users
Load More Posts